Shandong Xinhua Pharmaceutical Sets Out Board and Committee Structure

Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) has shared an update.

Shandong Xinhua Pharmaceutical Company Limited has disclosed the current composition of its board of directors, which includes executive, non-executive and independent non-executive members, with Mr. He Tongqing serving as chairman. The company has also detailed the structure of its four key board committees—Nomination, Remuneration and Appraisal, Audit and Strategic Development—clarifying the chairmanship and membership of each, which enhances transparency in its corporate governance framework for investors and other stakeholders.

The most recent analyst rating on (HK:0719) stock is a Hold with a HK$7.50 price target. To see the full list of analyst forecasts on Shandong Xinhua Pharmaceutical Company Limited Class H stock, see the HK:0719 Stock Forecast page.

More about Shandong Xinhua Pharmaceutical Company Limited Class H

Shandong Xinhua Pharmaceutical Company Limited is a China-based pharmaceutical manufacturer listed in Hong Kong under stock code 0719. The company operates in the healthcare and drug manufacturing industry, focusing on the development, production and sale of pharmaceutical products for domestic and international markets.

Average Trading Volume: 989,648

Technical Sentiment Signal: Buy

Current Market Cap: HK$9.8B

See more data about 0719 stock on TipRanks’ Stock Analysis page.